XenoTech, LLC16825 W. 116th Street Phone 913. 438.7450 |
|
XenoTech's reputation as a leader in drug metabolism research originated in 1983 with Dr. Andrew Parkinson's studies of cytochrome P450 (CYP) enzymes. Dr. Parkinson founded XenoTech in 1994 to provide products and contract research services to optimize the discovery, development and approval of drugs, food additives, nutraceuticals, agrochemicals, cosmetics and fragrances. XenoTech's products and services deliver information recommended by the US Food & Drug Administration to predict inter-individual variation in safety and drug efficacy, and to explain adverse reactions. XenoTech's scientists have performed drug development studies on over 1000 New Molecular Entities (NMEs) and, with extensive product offerings, have worked with hundreds of pharmaceutical, chemical, food, academic and regulatory organizations throughout the world.
Dr. Andrew Parkinson
Owner